Molecular Carcinogenesis

Molecular Carcinogenesis is a peer-reviewed journal dedicated to the molecular and cellular mechanisms underlying the initiation, progression, and prevention of cancer. Published by Wiley-Liss, Inc., this journal serves as a vital resource for researchers and clinicians focused on the genetic, epigenetic, and biochemical pathways that drive malignant transformation. The scope encompasses a broad range of topics, including oncogene and tumor suppressor gene function, signal transduction, DNA repair mechanisms, cell cycle regulation, apoptosis, and the molecular basis of tumor invasion and metastasis. Additionally, the journal highlights research on chemopreventive agents, molecular epidemiology, and the development of novel biomarkers for early detection and therapeutic targeting. The journal primarily publishes original research articles, along with comprehensive review articles, brief communications, and occasional special issues that synthesize emerging themes in the field. Its target audience includes molecular biologists, oncologists, pharmacologists, geneticists, and biomedical scientists investigating cancer biology at the molecular level. Molecular Carcinogenesis offers both subscription and open access options to authors, ensuring broad dissemination of high-impact findings. With a 2026 Impact Factor of 3.500 and a JCR Quartile ranking of Q2 in its category, the journal maintains a strong, respected position within the competitive landscape of cancer research publications, appealing to authors seeking a rigorous yet accessible venue for mechanistic studies that bridge fundamental molecular science and clinical oncology.